Manganese superoxide dismutase (SOD2) converts superoxide to oxygen plus hydrogen peroxide and serves as the primary defense against mitochondrial superoxide. Impaired SOD2 activity in humans has been associated with several chronic diseases, including ovarian cancer and type I diabetes, and SOD2 overexpression appears to suppress malignancy in cultured cells. We have produced a line of SOD2 knockout mice (SOD2m1BCM/SOD2m1BcM) that survive up to 3 weeks of age and exhibit several novel pathologic phenotypes including severe anemia, degeneration of neurons in the basal ganglia and brainstem, and progressive motor disturbances characterized by weakness, rapid fatigue, and circling behavior. In addition, SOD2m1BCM/SOD2m1BCM mice older than 7 days exhibit extensive mitochondrial injury within degenerating neurons and cardiac myocytes. Approximately 10% of SOD2m1BCM/SOD2m1BCM mice exhibit markedly enlarged and dilated hearts. These observations indicate that SOD2 deficiency causes increased susceptibility to oxidative mitochondrial injury in central nervous system neurons, cardiac myocytes, and other metabolically active tissues after postnatal exposure to ambient oxygen concentrations. Our SOD2-deficient mice differ from a recently described model in which homozygotes die within the first 5 days of life with severe cardiomyopathy and do not exhibit motor disturbances, central nervous system injury, or ultrastructural evidence of mitochondrial injury.
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Superoxide radicals produced as by-products of metabolic oxidation can cause extensive cellular injury, and several different superoxide dismutases (SODs) have evolved to inactivate both intracellular and extracellular superoxide (1) (2) (3) (4) (5) (6) (7) . Two closely related SODs containing either manganese or iron as cofactors are produced in most bacterial species, whereas most eukaryotic species contain at least two different intracellular SODs: (i) manganese superoxide (Mn SOD/SOD2) localized within the mitochondrial matrix and (ii) copper-and zinc-containing SOD1 (Cu/Zn SOD1/SOD1) localized predominantly in cytoplasmic and nuclear compartments (8) .
Another copper-and zinc-containing SOD found predominantly in extracellular compartments (EC SOD/SOD3) has recently been described (9) . Although Mn SOD is located within the mitochondrial matrix, the SOD2 gene encoding Mn SOD is located within nuclear chromosomal DNA (10) .
Yeast and bacterial mutants devoid of all SOD activities exhibit hypersensitivity to oxygen and redox compounds such as paraquat, and they survive ambient oxygen by using predominantly anaerobic metabolic pathways to minimize superoxide production (2, (11) (12) (13) . SODl-deficient mutants of Drosophila melanogaster are viable, but exhibit oxygen and paraquat sensitivity, decreased lifespan, and female infertility (14) . Although other potent antioxidants such as glutathione, ascorbate, and tocopherols are present to varying degrees within eukaryotic and prokaryotic cells, none of these inactivates superoxide as rapidly or effectively as SODs.
Several recent studies have suggested that decreased Mn SOD activity may be associated with one or more chronic diseases, including ovarian cancer (15, 16) and type I diabetes (17) (18) (19) . Mn SOD expression has also been shown to decrease metastatic potential and tumorigenicity in cultured cells (20) (21) (22) (23) (24) and to protect against neoplastic transformation by ionizing radiation (25) . The putative role of Mn SOD as a tumorsuppressor protein plus recent findings that mutations in the SOD1 gene are linked to amyotrophic lateral sclerosis (26) (27) (28) (29) (30) have led us to study the effects of a null SOD2 mutation on growth, development, and maturation in mice using homologous recombination. A line of SOD2-deficient mice has recently been shown to die within a few days after birth with cardiomyopathy and fatty liver, but without morphologic evidence of mitochondrial damage (31) . We have independently produced a line of SOD2 knockout mice (SOD2mlBCM/ SOD2mlBCM) that survive for up to 3 weeks of age and exhibit several novel pathologic phenotypes including severe anemia, degeneration of neurons in the basal ganglia and brainstem, and progressive motor disturbances characterized by weakness, rapid fatigue, and circling behavior. Marklund (34) with only minor modifications. One unit of SOD activity in this assay corresponds to 3 x 10-9 g of purified SOD1 (Sigma), and a minimum of 0.1 units could be reliably detected per reaction. Frozen tissues (-80°C) were thawed and homogenized in 10 vol of buffer, and SOD activity was extracted for 30 min at 4°C before centrifugation at 20,000 x g (9) . Potassium superoxide (Sigma) was added to each assay as described, and t'12 of superoxide was measured directly by A250 (34 -/-0.0 ± 0.0* 0.0446 Four 8 to 14 day-old homozygous mutant mice, plus four wild-type littermate controls, were used for this study. Data are represented in SOD units as determined by the direct SOD assay. Paired two-sample Student's t tests were conducted to obtain P values. A one-tailed and two-tailed test were applied to the Cu/Zn SOD and the Mn SOD data, respectively. WT, wild type. *All -/-SOD2 measurements resulted in activities of less than 0.1 unit, the detection limit for this assay. These were recorded as zero.
MATERIALS AND METHODS
0.25% CaCl2, 0.1 M sodium cacodylate buffer (pH 7.4), and specific regions of central nervous system (CNS), including cortex, basal ganglia and adjacent subcortical gray matter, brainstem, and spinal cord were individually dissected. Tissues were fixed overnight, dehydrated, and processed for electron microscopy as described (36) .
RESULTS
The SOD2 gene was inactivated by deletion of exons 1 and 2, plus -500 bp immediately 5' of exon 1 (Fig. 1A) sites, the mitochondrial targeting sequence, and one of three histidines that bind directly to the manganese cofactor (1, 3, (37) (38) (39) . Northern blots comparing steady-state SOD2 mRNA expression in mutant and wild-type mice indicate that SOD2mlBCM/+ heterozygotes contain -40% of wild-type SOD2 mRNA levels, and SOD2m1BCM/SOD2m1BcM mice do not contain detectable SOD2 mRNA (Fig. 1B) . In addition, assays of SOD activity indicate that any residual SOD2 activity in homozygotes is below limits of detection, whereas cyanidesensitive SOD levels are increased by -25% in SOD2mlBcm relative to wild-type mice (P = 0.016) ( Table 1) .
To assess whether SOD2 deficiency increases the frequency of embryonic lethality, we evaluated the genotypes of embryonic day 18. (Fig. 2,4) becomes readily apparent between days P2 and P7 and progresses until death by P18 (Fig. 2B) (Fig. 2A) . The small size and failure to thrive are not related to nursing difficulties, since milk is always noted in the stomachs of these mutants. In contrast to SOD2m1BCM/ SOD2m1BCM mice, SOD2mlBCM/+ mice are indistinguishable from wild-type mice with respect to size and growth rate (Fig.  2B ).
Histological analysis of tissues from SOD2m1BCM/ SOD2m1BCM mice reveals hypocellular bone marrow (Fig. 3 A and B), atypical patterns of glycogen deposition in hepatocytes (Fig. 3 C and D) , and an abundance of intracellular lipid vacuoles in hepatocytes (Fig. 3 E and F) . Within the bone marrow of SOD2m1BCM/SOD2m1BCM mice, all hematopoietic lineages appear to be reduced (Fig. 3A) , resulting in marked anemia at the time of death. The extent of marrow hypocellularity progresses with increasing age.
Analysis of the brain and spinal cord in SOD2m1BCM/ SOD2m1BCM mice by electron microscopy reveals degenerative injury to large CNS neurons, particularly in the basal ganglia and brainstem. This injury is characterized by extensive mitochondrial damage, loss of polysomes, and clearing of the cytoplasm (Fig. 4A) . We have also observed a relative absence of rough endoplasmic reticulum, focal dilatation of smooth endoplasmic reticulum, and ruffling of nuclear membranes in these cells. Cells surrounding the injured neurons are usually normal in appearance (Fig. 4A) . Similar degenerating neurons are lacking in littermate controls, despite extensive searches.
Although dilated cardiomyopathy in SOD2-deficient mice has previously been demonstrated (31) , only 10% of our SOD2m1BcM/SOD2m1BcM mice exhibit extreme balloon-like cardiac dilatation with thinning of the ventricular wall (Fig.  4C) . Electron microscopy of myocardium from these mice demonstrates widespread cellular injury and death characterized by swelling and fragmentation of mitochondria (Fig. 4D) and, in the most severely affected regions, by deposition of electron-dense material within mitochondria (Fig. 4E) . Analysis of the electron-dense mitochondria by energy dispersive x-ray elemental analysis (40) indicates that the mitochondrial densities in Fig. 4E do not contain calcium (data not shown), and we infer from these findings that the observed injury probably represents lipid peroxidation of mitochondrial membranes. Myocytes from SOD2mlBcM/SOD2mlBCM mice without extreme cardiac dilation exhibit increased accumulation of neutral lipid, but do not exhibit mitochondrial injury at the ultrastructural level (data not shown).
In addition to defects in growth and maturation, SOD2m1BcM/SOD2m1BcM mice exhibit striking and progressive motor and behavioral abnormalities including limb weakness, early onset of fatigue, and circling behavior. Limb strength was assessed in mice over 10 days of age by the ability to hold onto a bar suspended above the cage for at least 5 sec without falling, as well as by the ability to scale a 60°incline.
SOD2m1BcM/SOD2mlBCM mice perform poorly at both of these tasks relative to littermates. Fatigue was evaluated by comparing the endurance of homozygous, heterozygous, and wildtype mice after immersion into a small room-temperature water bath for a series of 1-min cycles. SOD2m1BCM/ SOD2mlBCM mice exhibited fatigue after 2-3 cycles, whereas control mice continued to swim actively after 10 cycles. DISCUSSION SOD2 deficiency causes selective mitochondrial injury in cells with obligatory requirements for high levels of oxidative metabolism, including cardiac myocytes, neurons, hepatocytes, and hematopoietic cells. The apparently normal embryonic development of SOD2m1BCM/SOD2m1BCM mice suggests that embryos are protected by a combination of low oxygen tension and relatively low levels of oxidative metabolism. This hypothesis is supported by observations indicating that fetal levels of Mn SOD in rodents and primates remain very low until relatively late in gestation (41, 42 Histological and ultrastructural evidence of mitochondrial injury in SOD2m1BcM/SOD2m1BCM mice has been detected predominantly in older mice (P8-P18), while inactivation of mitochondrial enzymes including aconitase and succinate dehydrogenase can be detected during the first week (31) . These findings suggest a model for mitochondrial oxidative damage in which superoxide-induced injury to soluble mitochondrial proteins compromises mitochondrial function and accelerates damage to mitochondrial membranes. Alternatively, the apparent hypersensitivity of soluble mitochondrial enzymes to superoxide may reflect the fact that ultrastructural injury to mitochondrial membranes represents a relatively insensitive assay.
SOD2m1BCM mutants, missing exons 1 and 2, survive for up to 18 days, and during the second and third weeks of life they develop CNS injury, motor abnormalities, and ultrastructural evidence of mitochondrial damage. These changes have not been seen in another SOD2-deficient model in which exon 3 has been deleted (SOD2mlUcsF) and the mice live only for 5 days (31). It is not immediately clear why some SOD2m1BCM mice outlive SOD2m1UcSF mice. The possibility of "leaky" expression of SOD2 in our model is highly unlikely considering the nature of our deletion construct. Moreover, Northern blots and direct SOD2 assays demonstrate that neither SOD2 mRNA nor activity can be detected in SOD2m1BcM homozygotes. The observation that cyanide-sensitive SOD levels are increased in SOD2m1BCM/SOD2m1BcM mice raises the additional possibility that levels of other antioxidants, such as glutathione or glutathione peroxidase, may also be increased.
